Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,479 across all filing types
Latest filing 2026-01-27 Transaction in Own Shar…
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification for sale of treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a formal notification regarding the sale of treasury shares by 'Sopharma' AD. It specifies the number of shares sold, the percentage of share capital, the total value, and the resulting balance of treasury shares held by the company. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share buybacks or sales of treasury shares.
2026-01-27 English
Notification from Bissera Lazarova under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000003260
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (PDMR), specifically a member of the Board of Directors of Sopharma AD. It follows the standard EU Market Abuse Regulation (MAR) template for reporting insider transactions, including details on the person, the issuer, the nature of the transaction (exercise of rights), and the date. This falls directly under the 'Director's Dealing' category.
2026-01-26 English
Notification from Bissera Lazarova under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000002262
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (Bissera Lazarova, a member of the Board of Directors of Sopharma AD). It explicitly references Article 19 of Regulation (EU) No 596/2014 (Market Abuse Regulation), which governs the disclosure of insider transactions. This is a standard template for reporting director/insider dealings.
2026-01-26 English
Notification from Bissera Lazarova under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000001264
Director's Dealing Classification · 100% confidence The document is a standard template for the notification of transactions by persons discharging managerial responsibilities (PDMRs) as required by Article 19 of the EU Market Abuse Regulation (MAR). It identifies a specific director (Bissera Lazarova) of Sopharma AD and details their transaction involving financial instruments. This falls directly under the 'Director's Dealing' category.
2026-01-26 English
Notification from Ivan Badinski under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000003260
Director's Dealing Classification · 100% confidence The document is a formal notification of a transaction by a person discharging managerial responsibilities (Ivan Badinski, a member of the Board of Directors of Sopharma AD). It explicitly references Regulation 596/2014 (Market Abuse Regulation) and follows the standard template for reporting insider dealings. This falls directly under the 'Director's Dealing' category.
2026-01-26 English
Notification from Ivan Badinski under Regulation 596/2014 for exercise of rights for issue of warrants with ISIN ą BG4000002262
Director's Dealing Classification · 100% confidence The document is a formal notification of an insider transaction under Article 19 of Regulation (EU) No 596/2014 (MAR). It explicitly identifies a person discharging managerial responsibilities (Ivan Badinski, a member of the Board of Directors of Sopharma AD) and details their transaction involving financial instruments. This fits the definition of a Director's Dealing (DIRS) filing.
2026-01-26 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.